- Pharmaceutical companies
- Astellas Pharma
Astellas Pharma
Phone: +61 2 9814 1100
Fax: + 61 2 9814 1120
Web: https://www.astellas.com/au/
| Type | Public (K.K) |
|---|---|
| Traded as |
|
| Industry | Pharmaceutical |
| Predecessors | Yamanouchi Pharmaceutical Fujisawa Pharmaceutical (Merged in 2005) |
| Founded | 1 April 2005 (2005-04-01) |
| Headquarters | 2-5-1, Nihonbashi-Honcho, Chūō-ku, Tokyo 103-8411, Japan |
| Key people | Kenji Yasukawa (President and CEO) |
| Products |
|
| Revenue | |
| Net income | |
| Total assets | $14.86 billion (2016) |
| Number of employees | 17,217 (2016) |
| Subsidiaries | Astellas US |
| Website | www.astellas.com/en/ |
The Astellas Group’s business philosophy has three elements — raison d'être, mission and beliefs. Raison D'être Contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products To go beyond all others in exploring and tapping the potential of the life sciences. To continue tackling new challenges and creating innovative pharmaceutical products. To deliver quality products along with accurate information and retain solid credibility among customers. To support healthy living for people around the world. To continue shining on the global pharmaceutical field. Mission Sustainable enhancement of enterprise value Astellas will seek to enhance its enterprise value in a sustainable manner. Astellas will seek to be the company of choice among all its stakeholders, including its customers, shareholders, employees, and the global community. Astellas will strive to gain the trust of all stakeholders and thereby enhance its enterprise value. Beliefs Our “beliefs” provide the code of conduct we prize at all times. Astellas will always be a group of people who act upon these beliefs. High Sense of Ethics We will always manage our business with the highest sense of ethics. Customer Focus We will always seek to understand customer needs and our focus will always be on achieving customer satisfaction. Creativity We will not be complacent and will always seek to innovate to create new value. Competitive Focus Our eyes will always be directed to the outside world, and we will continue to create better value faster. Astellas promises to perform its obligations toward all stakeholders by acting ethically and seeking to actively disclose information.
For detailed contact information visit location pages below.
Astellas Pharma's locations around the world
Clinical Trials sponsored by Astellas Pharma
-
Astellas Pharma s.r.o.CompletedPost-operative Peripheral Neuropathic PainCzech Republic
-
Astellas Pharma S.A.S.Completed
-
Astellas Pharma S.A.S.Completed
-
Astellas Pharma S.A.S.Completed
-
Astellas Pharma S.A.S.CompletedUse of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology (OLYMPE)Antifungal Prophylaxis | HaemopathyFrance
-
Astellas Pharma Korea, Inc.Not yet recruiting
-
Astellas Pharma Korea, Inc.RecruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaSouth Korea
-
Astellas Pharma Europe Ltd.CompletedUrologic Diseases | Urinary Bladder, Overactive | Urinary Bladder DiseasesGreece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
-
Astellas Pharma Korea, Inc.CompletedMetastatic Hormone-Sensitive Prostate CancerKorea, Republic of
-
Astellas Pharma China, Inc.CompletedGastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaChina